Vicarious Surgical (RBOTW) Change in Account Payables (2020 - 2025)
Vicarious Surgical (RBOTW) reported Change in Account Payables of $275000.0 for Q3 2025, up 587.5% year-over-year from $40000.0 in Q3 2024, and up 170.15% quarter-over-quarter from -$392000.0 in Q2 2025.
Vicarious Surgical (RBOTW) Change in Account Payables (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOTW) has 6 years of Change in Account Payables data on file, last reported at $275000.0 in Q3 2025.
- Change in Account Payables for Q3 2025 came in at $275000.0, up 587.5% year-over-year; the trailing twelve-month figure through Sep 2025 was -$495000.0 (down 266.67% YoY), and the FY2024 annual result was -$96000.0, up 79.7% from the prior year.
- Change in Account Payables climbed to $275000.0 in Q3 2025 per RBOTW's latest filing, from -$392000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $3.7 million in Q3 2022 and troughed at -$3.3 million in Q4 2022.
- A 5-year average of $22684.2 and a median of $14000.0 in 2024 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2021 and 2025: Change in Account Payables jumped 6748.41% in 2021, then tumbled 1135.71% in 2025.
- A 5-year view of Change in Account Payables shows it stood at $937000.0 in 2021, then sank by 447.71% to -$3.3 million in 2022, then soared by 91.65% to -$272000.0 in 2023, then gained by 14.34% to -$233000.0 in 2024, then surged by 218.03% to $275000.0 in 2025.
- Business Quant data shows RBOTW's Change in Account Payables at $275000.0 in Q3 2025, -$392000.0 in Q2 2025, and -$145000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Vicarious Surgical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 275,000.00 |
| Sep 30, 2025 | 275,000.00 |
| Jun 30, 2025 | -392,000.00 |
| Jun 30, 2025 | -392,000.00 |
| Mar 31, 2025 | -145,000.00 |
| Mar 31, 2025 | -145,000.00 |
| Dec 31, 2024 | -233,000.00 |
| Dec 31, 2024 | -233,000.00 |
| Sep 30, 2024 | 40,000.00 |
| Sep 30, 2024 | 40,000.00 |
| Jun 30, 2024 | 83,000.00 |
| Jun 30, 2024 | 83,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Dec 31, 2023 | -272,000.00 |
| Dec 31, 2023 | -272,000.00 |
| Sep 30, 2023 | -20,000.00 |
| Sep 30, 2023 | -20,000.00 |
| Jun 30, 2023 | -351,000.00 |
| Jun 30, 2023 | -351,000.00 |